Safety and chronic lesion characterization of pulsed field ablation in a Porcine model. (10th March 2021)

• Record Type: Journal Article
• Authors: Stewart, Mark T.; Haines, David E.; Miklavčič, Damijan; Kos, Bor; Kirchhof, Nicole; Barka, Noah; Mattison, Lars; Martien, Matt; Onal, Birce; Howard, Brian; Verma, Atul
• Is Part Of: Journal of cardiovascular electrophysiology. Volume 32:Number 4(2021)
• Page Start: 958
• Page End: 969
• Publication Date: 2021-03-10
• Subjects: atrial fibrillation -- catheter ablation -- electroporation -- pulsed electric field modeling -- pulsed field ablation; Blood vessels -- Physiology -- Periodicals; Electrophysiology -- Periodicals; Heart -- Physiology -- Periodicals; 612.1
• DOI: 10.1111/jce.14980
• Languages: English
• ISSNs: 1045-3873

Abstract

Abstract: Background: Pulsed field ablation (PFA) has been identified as an alternative to thermal‐based ablation systems for treatment of atrial fibrillation patients. The objective of this Good Laboratory Practice (GLP) study was to characterize the chronic effects and safety of overlapping lesions created by a PFA system at intracardiac locations in a porcine model. Methods: A circular catheter with nine gold electrodes was used for overlapping low‐ or high‐dose PFA deliveries in the superior vena cava (SVC), right atrial appendage (RAA), and right superior pulmonary vein (RSPV) in six pigs. Electrical isolation was evaluated acutely and chronic lesions were assessed via necropsy and histopathology after 4‐week survival. Acute and chronic safety data were recorded peri‐ and post‐procedurally. Results: No animal experienced ventricular arrhythmia during PFA delivery, and there was no evidence of periprocedural PFA‐related adverse events. Lesions created in all anatomies resulted in electrical isolation postprocedure. Lesions were circumferential, contiguous, and transmural, with all converting into consistent lines of chronic replacement fibrosis, regardless of trabeculated or smooth endocardial surface structure. Ablations were non‐thermally generated with only minimal post‐delivery temperature rises recorded at the electrodes. There was no evidence of extracardiac damage, stenosis, aneurysms, endocardial disruption, or thrombus. Conclusion: PFA deliveries to the SVC, RAA, and RSPV resulted in complete circumferential replacement fibrosis at 4‐week postablation with an excellent chronic myocardial and collateral tissue safety profile. This GLP study evaluated the safety and efficacy of a dosage range in preparation for a clinical trial and characterized the non‐thermal nature of PFA.